20.jpg
 

Introducing

ColGreen

Building an Australian Pharmaceutical Company, with Latin American operations, focused on the development, production and sale of cannabinoid products and pharmaceuticals Internationally.

OUR MISSION

ColGreen will set a new standard within Cannabis Life Sciences by producing and developing innovative products with key strategic partners in the industry. These partnerships contribute to our competitive advantages, which include low production costs, industrial-scale, high-quality, and global distribution.

In order for the cannabis industry to reach its full potential it must reliably supply consumers with a variety of high-quality, tested, consistent, and safe products at an affordable price.

All these are key strengths and capabilities of CGN.

18.jpg
7.jpg

OUR VISION

ColGreen’s vision is to be a leading cannabis company globally, providing investors with access to the most accretive cannabis opportunities around the world.

WHY COLGREEN       

Disruptive Innovation
- Numerous potentially patentable formulations
- Advancements in ingestion methods
- Developing target, high-resin genetic strains
High-Potential Platform
- Low cost of dried flower (<5c cost/gram; Colombia)
- Diversified, high-margin revenue streams (products & oils)
- Pipeline of acquisition targets & relationships
Reduced Operational Risk
- Rigorous, transparent governance model
- Execution, construction, operating expertise
- Large scale cultivation & extraction know-how

19.jpg
 

OUR TEAM

Strategic-Glenn-6.jpg

DIRECTOR

GLENN GAUDET

Glenn has more than 20 years of experience in establishing medium to large-scale consolidated businesses. This was accomplished by sourcing established, undervalued, profitable businesses and subsequently negotiating their purchase, securing and developing an experienced management team to lead the entity and raising significant funds through listing the entity on a stock exchange or through private investment. 

Glenn led the negotiation and acquisition of select businesses to form a consolidated group of veterinary practices which listed on the ASX as Greencross Ltd where he served as a director for 18 months post-IPO. 

DSC_0467 (1).jpg

CHIEF OPERATING OFFICER

francisco lemus

Mr Lemus, a practicing lawyer in Colombia, has accumulated experience across Australia, Colombia, Argentina, Chile and other parts of South America, working across mergers and acquisitions, project development, and commodity trading. He brings a specialist expertise of South American markets having worked across energy and resources, government transactions, professional services and logistics.

  • LinkedIn Social Icon